Cholesterol, LDL - Blood
Research News and Information

Monday, November 23, 2009

Effects of high-dose modified-release nicotinic acid on atherosclerosis and vascular function: a randomized, placebo-controlled, magnetic resonance imaging study.

Nov 2009 OBJECTIVES: Our aim was to determine the effects of high-dose (2 g) nicotinic acid (NA) on progression of atherosclerosis and measures of vascular function. BACKGROUND: NA raises high-density lipoprotein cholesterol (HDL-C) and reduces low-density ... Read more...

Improving chronic care of type 2 diabetes using teams of interprofessional learners.

30 Oct 2009 PURPOSE: To improve the care and outcomes of adult patients with type 2 diabetes by teaching interprofessional teams of learners the principles and practices of the Improving Chronic Illness Care Model. METHOD: The study population consisted of 384 ... Read more...

Evaluating the incremental benefits of raising high-density lipoprotein cholesterol levels during lipid therapy after adjustment for the reductions in other blood lipid levels.

24 Oct 2009 BACKGROUND: The role of high-density lipoprotein cholesterol (HDL-C) as a therapeutic target to prevent cardiovascular (CV) events remains unclear. We examined data from the Framingham Offspring Study from 1975 through 2003 to determine whether ... Read more...

Latest indexed articles for 'Cholesterol, LDL - Blood'

These are the very latest articles for this heading:

• Assessing niacin as an atherosclerosis therapeutic agent valuable insights provided by high-resolution vascular magnetic resonance imaging. Nov 2009
• Effects of high-dose modified-release nicotinic acid on atherosclerosis and vascular function: a randomized, placebo-controlled, magnetic resonance imaging study. Nov 2009
• Improving chronic care of type 2 diabetes using teams of interprofessional learners. 30 Oct 2009
• Evaluating the incremental benefits of raising high-density lipoprotein cholesterol levels during lipid therapy after adjustment for the reductions in other blood lipid levels. 24 Oct 2009
• The University of New Hampshire's Young Adult Health Risk Screening Initiative. 29 Sep 2009
• Hepatitis C virus infection and its clearance alter circulating lipids: implications for long-term follow-up. 29 Sep 2009
• Design of the DEFINE trial: determining the EFficacy and tolerability of CETP INhibition with AnacEtrapib. 29 Sep 2009
• Rationale and design of China intensive lipid lowering with statins in acute coronary syndrome: the CHILLAS study. 29 Sep 2009
• Mostly plants. 29 Sep 2009
• Effects of plant-based diets on plasma lipids. 29 Sep 2009
• Impact of coronary computed tomographic angiography findings on the medical treatment and control of coronary artery disease and its risk factors. 29 Sep 2009
• Paraoxonase variants relate to 10-year risk in coronary artery disease: impact of a high-density lipoprotein-bound antioxidant in secondary prevention. 27 Sep 2009
• Cardiovascular benefit of magnitude of low-density lipoprotein cholesterol reduction: a comparison of subgroups by age. 26 Sep 2009
• Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus. 23 Sep 2009
• Effects of increasing high-density lipoprotein cholesterol and decreasing low-density lipoprotein cholesterol on the incidence of first acute coronary events (from the Air Force/Texas Coronary Atherosclerosis Prevention Study). 13 Sep 2009
• Acute effects of statin therapy on coronary atherosclerosis following an acute coronary syndrome. 13 Sep 2009
• [Lower and lower cholesterol targets increase adverse effects] 30 Aug 2009
• LDL cholesterol is associated with blood pressure in Japanese women. 30 Aug 2009
• Structured patient education: the X-PERT Programme. 30 Aug 2009
• Growth curves for cardio-metabolic risk factors in children and adolescents. 30 Aug 2009

See a longer list of these articles.

Technical information about 'Cholesterol, LDL'

Definition: Cholesterol which is contained in or bound to low density lipoproteins (LDL), including CHOLESTEROL ESTERS and free cholesterol.

Registry Number: 0

Descriptor UI: D008078

Alternative terms: Cholesterol, LDL; Low Density Lipoprotein Cholesterol; beta-Lipoprotein Cholesterol; Cholesterol, beta-Lipoprotein; beta Lipoprotein Cholesterol; LDL Cholesterol; Cholesteryl Linoleate, LDL; LDL Cholesteryl Linoleate;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; deficiency; diagnostic use; drug effects; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; physiology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; ultrastructure; urine; chemistry; contraindications; agonists;

Tree Number: D10.532.515.500; D10.570.938.208.275; D12.776.521.550.500;

History Note: 2007 (1985)